New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
12:20 EDTMCK, CVS, RAD, WAGRite Aid slides after posting a steeper decline in profit vs. last year
Shares of retail drugstore chain Rite Aid (RAD) are falling after the company reported that its first quarter profit was down significantly from the year-ago period. WHAT'S NEW: Rite Aid reported Q1 earnings per share of 4c, matching analyst's expectations, but below the 9c it reported last year. Revenue for the quarter was $6.47B, slightly higher than expectations of $6.43B ad $6.3B in the prior year quarter. Rite Aid's Q1 same-store sales were up 3.1% over the prior year period. The retailer reported net income of $41.4M, well below the company's net income at this time last year of $89.7M. A decrease in adjusted EBITDA and higher income tax expense contributed to this result and these factors were partially offset by lower interest expense and a lower LIFO charge. Rite Aid confirmed that it sees fiscal year 2015 EPS in the range of 30c-40c, while analysts estimate that EPS will be 35c. The company still sees FY15 revenue to be between $26B-$26.5B, which is in line with analyst's consensus of $26.19B. The retailer confirmed that it sees FY15 SSS of up to 2.5%-4.5% vs. fiscal year 2014. WHAT'S NOTABLE: During the company's Q1 earnings conference call, Rite Aid said that as it more aggressively pursues opportunities for growth, it is prepared to increase allocation for prescription file buys if additional opportunities arise throughout the fiscal year. The retailer expects the current competitive environment to remain promotional and is also considering plan wages and benefit increases. Rite Aid said that it increased its expected working capital benefit to $250M from $150M as a result of the McKesson (MCK) agreement and says the working capital benefit will not be fully realized until the fourth quarter. As the company mentioned on its FY14 earnings call in April, it expected the second half of FY15 to be stronger than the first two quarters due in part to the strength of FY14's first half as well as the introduction of new generics in 2H15. Rite Aid anticipates closing a total of 40 stores of which the guidance includes a store lease closing provision for FY15 to balance closing upon lease expiration. ANALYST REACTION: UBS analyst Scott Arwin said that generic drug MAC-ing by pharmacy benefit managers was a component in Rite Aid's Q1 earnings falling below predictions. He said that the retailer's management suggested that historically, they would usually have some ability to go back to generic manufacturers to offset some of the MAC reimbursement cuts. In this situation, however, Arwin said the company is currently hindered temporarily on their ability to do this during the transition of its generic procurement over to McKesson. Ride Aid suggested that this will also impact second quarter results as well, Arwin said. UBS maintains its Neutral rating on the drugstore franchise and raised its price target to $7.50 from $7.00. PRICE ACTION: During afternoon trading, Rite Aid was down 24c or 3.23%, to $7.20. OTHERS TO WATCH: Rite Aid peer Walgreen Company (WAG) was down around 0.8% to $75.45, while CVS Caremark (CVS) was up moderately to $77.46.
News For RAD;MCK;WAG;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 9, 2016
06:55 EDTCVSCVS Health backs Q1 adjusted EPS view of $1.14-$1.17
Subscribe for More Information
06:53 EDTCVSCVS Health reports Q4 pharmacy same store prescription volumes up 5%
06:53 EDTCVSCVS Health reports Q4 SSS up 3.5%
Subscribe for More Information
06:52 EDTCVSCVS Health reports Q4 adjusted EPS $1.53, consensus $1.53
Reports Q4 revenue $41.15B, consensus $4.18B.
February 8, 2016
14:28 EDTCVSNotable companies reporting before tomorrow's open
Subscribe for More Information
07:58 EDTCVSCVS Health volatility elevated into Q4 and outlook
Subscribe for More Information
February 5, 2016
12:26 EDTRADOptions with increasing implied volatility
Subscribe for More Information
February 4, 2016
09:16 EDTRADRite Aid shareholders approve merger with Walgreens Boots Alliance
Subscribe for More Information
February 3, 2016
14:13 EDTRADRite Aid to host special shareholder meeting
Subscribe for More Information
11:03 EDTRADOptions with increasing implied volatility: LC RAD CIEN ADSK BWLD
Subscribe for More Information
09:32 EDTCVSCVS Health initiated with an Overweight at Atlantic Equities
Target $114.
February 2, 2016
10:39 EDTRADOptions with increasing implied volatility: LC RAD CIEN
09:56 EDTRADRite Aid's RediClinic, Aria Health announce alliance
Subscribe for More Information
09:02 EDTMCKLafayette Radiology picks McKesson for revenue cycle management services
Lafayette Radiology, based in Lafayette, Indiana, has tapped McKesson Business Performance Services to provide a full range of revenue cycle management services, including ICD-10 education and support. Services will include documentation training, coding, claims management, denial management, compliance and business intelligence reporting.
February 1, 2016
13:20 EDTCVSCVS Health to make overdose-reversing drug available without prescription in OH
Subscribe for More Information
10:51 EDTCVSActive calls; INTC CVS TWTR APC BAC
Subscribe for More Information
10:25 EDTRADWilliaOptions with increasing implied volatility: WMB ENDP RAD
Subscribe for More Information
January 29, 2016
10:16 EDTRADOptions with increasing implied volatility: WMB W CERS RAD CRM GILD MNST
Subscribe for More Information
January 28, 2016
10:32 EDTRADOptions with increasing implied volatility: RAD GMCR
08:32 EDTRADRite Aid reports January SSS down 1.4%
For the four weeks ended Jan. 23, 2016, same store sales decreased 1.4% over the prior-year period. January front-end same store sales decreased 1.9%. Pharmacy same store sales, which included an approximate 242 basis points negative impact from new generic introductions, decreased 1.2%. Prescription count at comparable stores decreased 1% over the prior-year period. Total drugstore sales for the four-week period decreased 1.3% with sales of $2B compared to $2.026B for the same period last year. Prescription sales accounted for 70.5% of drugstore sales, and third party prescription sales represented 97.7% of pharmacy sales.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use